244 related articles for article (PubMed ID: 24685909)
1. Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history.
Sparks JA; Chen CY; Jiang X; Askling J; Hiraki LT; Malspeis S; Klareskog L; Alfredsson L; Costenbader KH; Karlson EW
Ann Rheum Dis; 2015 Aug; 74(8):1522-9. PubMed ID: 24685909
[TBL] [Abstract][Full Text] [Related]
2. Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis.
Karlson EW; Ding B; Keenan BT; Liao K; Costenbader KH; Klareskog L; Alfredsson L; Chibnik LB
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1147-56. PubMed ID: 23495093
[TBL] [Abstract][Full Text] [Related]
3. Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk.
Karlson EW; Chibnik LB; Kraft P; Cui J; Keenan BT; Ding B; Raychaudhuri S; Klareskog L; Alfredsson L; Plenge RM
Ann Rheum Dis; 2010 Jun; 69(6):1077-85. PubMed ID: 20233754
[TBL] [Abstract][Full Text] [Related]
4. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.
Ding B; Padyukov L; Lundström E; Seielstad M; Plenge RM; Oksenberg JR; Gregersen PK; Alfredsson L; Klareskog L
Arthritis Rheum; 2009 Jan; 60(1):30-8. PubMed ID: 19116921
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis.
Meng W; Zhu Z; Jiang X; Too CL; Uebe S; Jagodic M; Kockum I; Murad S; Ferrucci L; Alfredsson L; Zou H; Klareskog L; Feinberg AP; Ekström TJ; Padyukov L; Liu Y
Arthritis Res Ther; 2017 Mar; 19(1):71. PubMed ID: 28356135
[TBL] [Abstract][Full Text] [Related]
6. Regional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.
Källberg H; Vieira V; Holmqvist M; Hart JE; Costenbader KH; Bengtsson C; Klareskog L; Karlson EW; Alfredsson L
Scand J Rheumatol; 2013; 42(5):337-43. PubMed ID: 23611369
[TBL] [Abstract][Full Text] [Related]
7. Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden.
Frisell T; Hellgren K; Alfredsson L; Raychaudhuri S; Klareskog L; Askling J
Ann Rheum Dis; 2016 Jan; 75(1):183-9. PubMed ID: 25498119
[TBL] [Abstract][Full Text] [Related]
8. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.
Frisell T; Holmqvist M; Källberg H; Klareskog L; Alfredsson L; Askling J
Arthritis Rheum; 2013 Nov; 65(11):2773-82. PubMed ID: 23897126
[TBL] [Abstract][Full Text] [Related]
9. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study.
Bengtsson C; Padyukov L; Källberg H; Saevarsdottir S
Ann Rheum Dis; 2014 Jun; 73(6):1096-100. PubMed ID: 23613482
[TBL] [Abstract][Full Text] [Related]
10. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
[TBL] [Abstract][Full Text] [Related]
11. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Orellana C; Saevarsdottir S; Klareskog L; Karlson EW; Alfredsson L; Bengtsson C
Ann Rheum Dis; 2017 Nov; 76(11):1845-1852. PubMed ID: 28818831
[TBL] [Abstract][Full Text] [Related]
13. Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study.
Wesley A; Bengtsson C; Elkan AC; Klareskog L; Alfredsson L; Wedrén S;
Arthritis Care Res (Hoboken); 2013 Jan; 65(1):107-12. PubMed ID: 22674870
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
15. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.
Young KA; Deane KD; Derber LA; Hughes-Austin JM; Wagner CA; Sokolove J; Weisman MH; Buckner JH; Mikuls TR; O'Dell JR; Keating RM; Gregersen PK; Robinson WH; Holers VM; Norris JM
Arthritis Rheum; 2013 Aug; 65(8):1995-2004. PubMed ID: 23754702
[TBL] [Abstract][Full Text] [Related]
16. To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?
Jiang X; Frisell T; Askling J; Karlson EW; Klareskog L; Alfredsson L; Källberg H
Arthritis Rheumatol; 2015 Feb; 67(2):352-62. PubMed ID: 25418518
[TBL] [Abstract][Full Text] [Related]
17. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study.
Arkema EV; Goldstein BL; Robinson W; Sokolove J; Wagner CA; Malspeis S; Rosner B; Grodstein F; Karlson EW; Costenbader KH
Arthritis Res Ther; 2013 Oct; 15(5):R159. PubMed ID: 24286474
[TBL] [Abstract][Full Text] [Related]
18. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
van Heemst J; Hensvold AH; Jiang X; van Steenbergen H; Klareskog L; Huizinga TW; van der Helm-van Mil A; Catrina AI; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2016 Oct; 75(10):1891-8. PubMed ID: 26715653
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction models for incident systemic lupus erythematosus among women in the Nurses' health study cohorts using genetics, family history, and lifestyle and environmental factors.
Cui J; Malspeis S; Choi MY; Lu B; Sparks JA; Yoshida K; Costenbader KH
Semin Arthritis Rheum; 2023 Feb; 58():152143. PubMed ID: 36481507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
